Thiosulfate leaching is emerging as a promising alternative to traditional cyanidation methods in gold extraction. This process utilises thiosulfate as a lixiviant, offering enhanced environmental ...

Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...

The US Food and Drug Administration (FDA) has approved sodium thiosulfate (Pedmark, Fennec Pharmaceuticals) injection to reduce the risk for ototoxicity associated with cisplatin in pediatric patients ...

Vials of drug Currently, there is no approved therapy for calciphylaxis. Intravenous sodium thiosulfate does not improve skin lesions or reduce the risk of dying from calciphylaxis, a rare but ...

New studies highlight how thiosulfates not only supply sulfur but also significantly reduce nitrogen loss by slowing the conversion of ammonium to nitrate in the soil. Since 2017, Dr. Zack Ogles, ...

Metallic gold is known for its electrochemical nobility, and resulting lack of reactivity. Thus, it is usually accepted to be a non-allergenic metal. For this reason, contact dermatitis due to gold ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Use of sodium thiosulfate to treat calciphylaxis in patients on peritoneal dialysis can be ...

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71 st Annual ...

The evaluation committee considered evidence submitted by Norgine, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for ...

No medication is currently approved to treat vascular calcification in this population. Intravenous sodium thiosulfate (STS) may slow the progression of vascular calcification and arterial stiffness ...

~ PEDMARK® is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic Solid Tumors ~ The FDA ...